Cerner Corp (CERN, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Cerner Corp is a supplier of healthcare information technology and offers software, professional services, medical device integration, remote hosting and employer health, and wellness services. The Domestic segment generates maximum revenue. Cerner Corp has a market cap of $18.45 billion; its shares were traded at around $56.01 with a P/E ratio of 22.41 and P/S ratio of 3.47. Cerner Corp had annual average EBITDA growth of 14.00% over the past ten years. GuruFocus rated Cerner Corp the business predictability rank of 5-star.
For the last quarter Cerner Corp reported a revenue of $1.4 billion, compared with the revenue of $1.3 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $5.4 billion, an increase of 4.4% from last year. For the last five years Cerner Corp had an average revenue growth rate of 13.3% a year. The Cerner Corp had a decent operating margin of 14.44%, compared with the operating margin of 18.68% a year before. The 10-year historical median operating margin of Cerner Corp is 19.21%. The profitability rank of the company is 9 (out of 10).
At the end of the fiscal year, Cerner Corp has the cash and cash equivalents of $374.1 million, compared with $370.9 million in the previous year. The long term debt was $438.8 million, compared with $515.1 million in the previous year. The interest coverage to the debt is 3.7. Cerner Corp has a financial strength rank of 7 (out of 10).
At the current stock price of $56.01, Cerner Corp is traded at 23.4% discount to its historical median P/S valuation band of $73.15. The P/S ratio of the stock is 3.47, while the historical median P/S ratio is 4.54. The intrinsic value of the stock is $26.75 a share, according to GuruFocus DCF Calculator. The stock lost 12.41% during the past 12 months.
For the complete 20-year historical financial data of CERN, click here.
